Prediabetes: Fasting Glucose and HbA1c Before Diabetes Sets In

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Blood testing for prediabetes measures fasting glucose and HbA1c to reveal early disruptions in glucose regulation—catching the window before diabetes when lifestyle changes are most effective. Fasting glucose of 100–125 mg/dL or HbA1c of 5.7–6.4% signals prediabetes, when risks for heart disease, stroke, and kidney disease begin rising. Together, these markers provide the strongest early signal of insulin resistance and guide personalized diet, activity, and weight decisions.

Read more →

Understand what your blood sugar metabolic testing results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Prediabetes and the quiet drift in glucose control

Prediabetes biomarkers are blood signals that show how your body handles sugar—before diabetes sets in. They capture sugar levels now (glucose), sugar exposure over time (hemoglobin A1c), and the hormones that control it (insulin, C‑peptide). Together they reveal whether cells are growing less responsive to insulin (insulin resistance) and whether the pancreas is working harder to keep up (β‑cell stress). Some tests focus on the rise after eating (postprandial glycemia) or how the liver releases sugar overnight (hepatic glucose output). Because these markers come from everyday physiology—glucose circulating in blood, red blood cells picking up sugar, and insulin released from the pancreas—they translate silent, early changes into measurable facts. That makes them powerful for spotting risk, timing interventions, and tracking the impact of nutrition, sleep, activity, and medications. In short, prediabetes biomarkers map the conversation between sugar and insulin across minutes and months, so you and your clinician can see where regulation is slipping and act before damage occurs.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why glucose and HbA1c matter before diabetes

Fasting glucose and HbA1c reveal how tightly your body controls blood sugar—moment to moment and across months. When glucose stays high, proteins glycate, vessels stiffen, and the pancreas, nerves, kidneys, eyes, and brain accrue quiet injury. Typical fasting glucose sits in the 70s–90s; 100–125 signals prediabetes. HbA1c below 5.7 is typical; 5.7–6.4 marks prediabetes. Optimal tends to the lower-normal range—fasting in the 70s–90s, HbA1c about 5.0–5.4—without hypoglycemia. When values fall low, glucose supply lags insulin action. Levels under ~70 can bring shakiness, sweating, hunger, dizziness, or confusion; children feel lows more abruptly, older adults may have muted warnings. Such lows generally argue against prediabetes, though they can coexist with wide swings. A very low HbA1c can reflect frequent lows or shortened red‑cell lifespan (hemolysis, recent blood loss). In pregnancy, fasting glucose trends lower and HbA1c is less reliable. Higher fasting glucose or a creeping HbA1c reflects hepatic insulin resistance and loss of first‑phase insulin release, with post‑meal spikes. Symptoms are often subtle—post‑meal fatigue, more thirst or urination near the diabetic range. Men more often show fasting elevation first; women may show post‑meal rises and face gestational diabetes risk. Big picture: these markers connect metabolism to vascular, liver, and brain health. Even in prediabetes, risks for heart disease, stroke, kidney disease, retinopathy, neuropathy, and fatty liver rise, so early detection is clinically important.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

The honest scope of a prediabetes screen

Prediabetes blood testing provides a window into how your body manages energy, with direct implications for metabolism, cardiovascular health, brain function, reproductive balance, and immune resilience. At Superpower, we focus on two key biomarkers: Glucose and HbA1c. These tests help reveal how efficiently your body processes and regulates blood sugar, a central factor in overall system health. Glucose is the main sugar circulating in your blood, serving as a primary energy source for cells. HbA1c, or glycated hemoglobin, reflects your average blood sugar levels over the past two to three months. Together, these markers help identify early disruptions in glucose regulation—what we call prediabetes—before more serious metabolic problems develop. Stable glucose and a healthy HbA1c indicate that your body is effectively moving sugar from the bloodstream into cells, supporting steady energy, clear thinking, and balanced hormone function. When these markers are elevated, it suggests that your system is struggling to keep blood sugar in check, which can stress blood vessels, nerves, and organs over time. It’s important to note that factors such as pregnancy, age, acute illness, certain medications, and even differences in laboratory methods can influence glucose and HbA1c results. These variables should be considered when interpreting your numbers to ensure an accurate understanding of your metabolic health.

Frequently Asked Questions

References

  1. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M (2012). Prediabetes: A high-risk state for diabetes development. *Lancet*, *379*(9833), 2279-2290. https://doi.org/10.1016/S0140-6736(12)60283-9
  2. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK (2016). Significance of HbA1c test in diagnosis and prognosis of diabetic patients. *Biomarker Insights*, *11*, 95-104. https://doi.org/10.4137/BMI.S38440
  3. Greenberg AS, Obin MS (2006). Obesity and the role of adipose tissue in inflammation and metabolism. *The American Journal of Clinical Nutrition*, *83*(2), 461S-465S. https://doi.org/10.1093/ajcn/83.2.461S
  4. Ridker PM (2003). Clinical application of C-reactive protein for cardiovascular disease detection and prevention. *Circulation*, *107*(3), 363-369. https://doi.org/10.1161/01.CIR.0000053730.47739.3C
  5. National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). *Prediabetes & insulin resistance*. https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey